Cost-Effectiveness of Biologics for Allergic Diseases
Ann Chen Wu, Anne L. Fuhlbrigge, Maria Acosta Robayo, Marcus Shaker
Topics & Concepts
MedicineOmalizumabNasal polypsGranulomatosis with polyangiitisAsthmaAtopic dermatitisEosinophilicDermatologySinusitisIntensive care medicineMepolizumabCost effectivenessBiologic AgentsImmunologyImmunoglobulin EEosinophilInternal medicineAntibodyVasculitisDiseasePathologyRisk analysis (engineering)Rheumatoid arthritisAsthma and respiratory diseasesAllergic Rhinitis and SensitizationRespiratory and Cough-Related Research